Breast Cancer Research (Jan 2020)

Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

  • Samuel A. Jacobs,
  • André Robidoux,
  • Jame Abraham,
  • José Manuel Pérez-Garcia,
  • Nicla La Verde,
  • James M. Orcutt,
  • Marina E. Cazzaniga,
  • Fanny Piette,
  • Silvia Antolín,
  • Elena Aguirre,
  • Javier Cortes,
  • Antonio Llombart-Cussac,
  • Serena Di Cosimo,
  • Rim S. Kim,
  • Huichen Feng,
  • Corey Lipchik,
  • Peter C. Lucas,
  • Ashok Srinivasan,
  • Ying Wang,
  • Nan Song,
  • Patrick G. Gavin,
  • April D. Balousek,
  • Soonmyung Paik,
  • Carmen J. Allegra,
  • Norman Wolmark,
  • Katherine L. Pogue-Geile

DOI
https://doi.org/10.1186/s13058-019-1240-y
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 2

Abstract

Read online

After the publication of this work [1] the authors have reported that in Table 3 The letter “T” in columns 5 and 7 should not be there.